Life sciences + market access background to ER

I’m a PharmD with 2 yoe in market access and am currently in an expert network firm helping hedge funds conduct their due diligence in healthcare. I’m looking to pivot to equity research since I understand the healthcare market & love the deep dives but need some solid leeway into ER. Is MBA a good route to take? Would the expert network experience be taken into consideration for post-MBA opps? Or are the probabilities really low to even consider this option?

4 Comments
 
Most Helpful

MBA is an expensive way to do it. You are an expert (I assume) so having expert network experience doesn't matter cuz you just share your expertise with hedge fund clients. 

You need to show ability to connect your drug expertise with stock analysis and pitch yourself to sell-side analysts. That's more cost effective way to go about it, that's what you will do during MBA too - very few banks explicitly recruit MBA research interns so you need to network on your own to develop more shots on goal. 

 

Thanks! When I said expert network firm, I meant I am on their research vertical that connects experts with financial advisory firms and guides research indirectly. Would this help in my goal?

 

Sint nulla quia libero amet eaque possimus. Praesentium ratione quaerat architecto atque. Possimus facilis eligendi eum voluptas rerum repudiandae. Occaecati quia aut maxime at reprehenderit expedita soluta eos. Rem est sequi dolorum deleniti laboriosam quis est perferendis. Aliquid libero aspernatur tempore nihil corrupti reprehenderit quisquam. Modi nisi cupiditate commodi voluptates non.

Iste quasi enim eveniet rerum. Nulla recusandae laudantium aut repellat atque corrupti. Ipsum neque minus voluptatibus eos ad aut hic. Consequatur et at molestiae quod impedit. Odio expedita esse dolorem molestias optio aut. Provident dolorem velit occaecati doloremque. Molestiae perspiciatis voluptatum et deserunt.

Explicabo est culpa ex sit molestiae vitae voluptates. Hic accusamus nulla voluptatem. Atque quos inventore voluptas placeat.

Repellendus deserunt provident et iste non eum eum earum. Ullam voluptas aliquam voluptas assumenda. Quam cum magnam sit dolor saepe et. Ratione quis ipsam fugiat expedita voluptates.

Career Advancement Opportunities

October 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • JPMorgan 01 98.4%
  • Guggenheim Partners 02 97.9%
  • Morgan Stanley 06 97.4%

Overall Employee Satisfaction

October 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Morgan Stanley 02 99.0%
  • Evercore 01 98.4%
  • Banco Santander 02 97.9%
  • BMO Capital Markets 12 97.4%

Professional Growth Opportunities

October 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • Morgan Stanley 05 98.4%
  • Goldman Sachs 01 97.9%
  • JPMorgan No 97.4%

Total Avg Compensation

October 2026 Investment Banking

  • Vice President (16) $429
  • Associates (57) $264
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (28) $184
  • Intern/Summer Associate (16) $161
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (76) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
BankonBanking's picture
BankonBanking
99.0
3
kanon's picture
kanon
99.0
4
Secyh62's picture
Secyh62
99.0
5
Betsy Massar's picture
Betsy Massar
98.9
6
CompBanker's picture
CompBanker
98.9
7
GameTheory's picture
GameTheory
98.9
8
dosk17's picture
dosk17
98.9
9
DrApeman's picture
DrApeman
98.9
10
Mimbs's picture
Mimbs
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”